Business
Warren Buffett bought 4 pharma giants in Q3 // Motley Fool Australia
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) filed its Form 13F with the Securities and Exchange Commission on Monday, which gave investors a look at what the Oracle of Omaha and his team of investors bought in the third quarter.
Among the list were four pharmaceutical companies: AbbVie (NYSE: ABBV), Merck (NYSE: MRK), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). The first three were similarly sized purchases of around $1.8 billion. The Pfizer purchase was substantially smaller, with a market value around $136 million.
Within the industry, there doesn’t seem to be a theme among the four drugmakers.
Merck…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business23 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News20 hours agoMan dies after stabbing in inner-city unit
-
Noosa News23 hours agoThe Almond Ashes sees Australia and India mix business and cricket